Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Tailoring therapy for patients with multiple myeloma to improve outcomes

Elizabeth O’Donnell, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the importance of tailoring treatment approaches for patients with multiple myeloma. Decisions should be made by taking into account factors such as the patient’s age, frailty and comorbidities, as well as the side effects of agents being used. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.